{"title":"测定痴呆患者处方药物中抗胆碱能药物的使用。","authors":"Brooke Ellard, John A Galdo","doi":"10.4140/TCP.n.2017.764","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>The primary endpoint of the study is to determine the variations in the use of medications to treat dementia in patients concomitantly or not prescribed anticholinergics.</p><p><strong>Design: </strong>The study is a case series of patients at a single community pharmacy over one year based on prescription claims data.</p><p><strong>Setting: </strong>The setting is an independent community pharmacy in the South.</p><p><strong>Main outcome measure(s): </strong>The main outcome is the variations associated in treatment plans for patients either receiving anticholinergics or not receiving medications with anticholinergic properties.</p><p><strong>Results: </strong>The community pharmacy had 33 patients on medications to treat dementia, and 17 patients (51.5%) were prescribed anticholinergic medications. Only patients on anticholinergic medications were prescribed memantine immediate-release. Fifteen patients (93%) not prescribed anticholinergic medications were on a single medication to treat dementia, whereas 9 patients (52%) prescribed anticholinergic medications were on a single medication to treat dementia.</p><p><strong>Conclusion: </strong>Further research should be conducted in this area to better ascertain the impact anticholinergic medications have on patients. This study noted differences from previous data regarding the prevalence of concomitant prescribing of medications for the treatment of dementia and anticholinergics.</p>","PeriodicalId":45985,"journal":{"name":"CONSULTANT PHARMACIST","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2017-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4140/TCP.n.2017.764","citationCount":"1","resultStr":"{\"title\":\"Determination of Anticholinergic Medication Use in Patients Prescribed Medications for the Treatment of Dementia.\",\"authors\":\"Brooke Ellard, John A Galdo\",\"doi\":\"10.4140/TCP.n.2017.764\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>The primary endpoint of the study is to determine the variations in the use of medications to treat dementia in patients concomitantly or not prescribed anticholinergics.</p><p><strong>Design: </strong>The study is a case series of patients at a single community pharmacy over one year based on prescription claims data.</p><p><strong>Setting: </strong>The setting is an independent community pharmacy in the South.</p><p><strong>Main outcome measure(s): </strong>The main outcome is the variations associated in treatment plans for patients either receiving anticholinergics or not receiving medications with anticholinergic properties.</p><p><strong>Results: </strong>The community pharmacy had 33 patients on medications to treat dementia, and 17 patients (51.5%) were prescribed anticholinergic medications. Only patients on anticholinergic medications were prescribed memantine immediate-release. Fifteen patients (93%) not prescribed anticholinergic medications were on a single medication to treat dementia, whereas 9 patients (52%) prescribed anticholinergic medications were on a single medication to treat dementia.</p><p><strong>Conclusion: </strong>Further research should be conducted in this area to better ascertain the impact anticholinergic medications have on patients. This study noted differences from previous data regarding the prevalence of concomitant prescribing of medications for the treatment of dementia and anticholinergics.</p>\",\"PeriodicalId\":45985,\"journal\":{\"name\":\"CONSULTANT PHARMACIST\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2017-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.4140/TCP.n.2017.764\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"CONSULTANT PHARMACIST\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4140/TCP.n.2017.764\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"CONSULTANT PHARMACIST","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4140/TCP.n.2017.764","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Determination of Anticholinergic Medication Use in Patients Prescribed Medications for the Treatment of Dementia.
Objective: The primary endpoint of the study is to determine the variations in the use of medications to treat dementia in patients concomitantly or not prescribed anticholinergics.
Design: The study is a case series of patients at a single community pharmacy over one year based on prescription claims data.
Setting: The setting is an independent community pharmacy in the South.
Main outcome measure(s): The main outcome is the variations associated in treatment plans for patients either receiving anticholinergics or not receiving medications with anticholinergic properties.
Results: The community pharmacy had 33 patients on medications to treat dementia, and 17 patients (51.5%) were prescribed anticholinergic medications. Only patients on anticholinergic medications were prescribed memantine immediate-release. Fifteen patients (93%) not prescribed anticholinergic medications were on a single medication to treat dementia, whereas 9 patients (52%) prescribed anticholinergic medications were on a single medication to treat dementia.
Conclusion: Further research should be conducted in this area to better ascertain the impact anticholinergic medications have on patients. This study noted differences from previous data regarding the prevalence of concomitant prescribing of medications for the treatment of dementia and anticholinergics.
期刊介绍：
Vision ... The Society"s long-term desire, aspiration, and core purpose. The vision of the American Society of Consultant Pharmacists is optimal medication management and improved health outcomes for all older persons. Mission ... The Society"s strategic position, focus, and reason for being. The American Society of Consultant Pharmacists empowers pharmacists to enhance quality of care for all older persons through the appropriate use of medication and the promotion of healthy aging.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
